Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in córdoba Province, Argentina

Applied and Environmental Microbiology

Volumn 75, Issue 5, 2009, Pages 1395-1401

  Mueller, Judith E ^a   Bessaud, Maël ^b   Huang, Q Sue ^c   Martinez, Laura C ^d   Barril, Patricia A ^d   Morel, Viviane ^b   Balanant, Jean ^b   Bocacao, Judy ^c   Hewitt, Joanne ^c   Gessner, Brad D ^a   Delpeyroux, Francis ^b   Nates, Silvia V ^d  

^a Agence de Medecine Preventive   (France)

^b INSTITUT PASTEUR   (France)

^c INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^d UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ARGENTINA; GENETIC DIVERGENCES; GENETIC INSTABILITIES; MIDDLE-INCOME COUNTRIES; POLIOVIRUS; SEROTYPES; TEMPERATE CLIMATES; VACCINE STRAINS; WASTEWATER SAMPLES;

CLIMATOLOGY; ENCODING (SYMBOLS); STRAIN; VIRUSES; WASTEWATER;

VACCINES;

COMPARATIVE STUDY; ENVIRONMENTAL RISK; IMMUNIZATION; MUTATION; POLIOMYELITIS; RISK ASSESSMENT; TEMPERATE ENVIRONMENT; VACCINE; VIRUS; WASTEWATER; WORLD HEALTH ORGANIZATION;

ARGENTINA; BASE SEQUENCE; CAPSID PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; POLIOVIRUS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL; SEQUENCE ALIGNMENT; SEWAGE; VIRUS SHEDDING;

ARGENTINA; CORDOBA [ARGENTINA]; SOUTH AMERICA;

POLIOVIRUS;

EID: 61649099101     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02201-08     Document Type: Article

References (40)

1. Blomqvist, S., A. L. Bruu, M. Stenvik, and T. Hovi. 2003. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1. J. Gen. Virol. 84:573-580.
2. Bouchard, M. J., D. H. Lam, and V. R. Racaniello. 1995. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J. Virol. 69:4972-4978.
3. Chumakov, K. M., L. P. Norwood, M. L. Parker, E. M. Dragunsky, Y. X. Ran, and I. S. Levenbook. 1992. RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence. J. Virol. 66:966-970.
4. Cuervo, N. S., S. Guillot, N. Romanenkova, M. Combiescu, M., A. Aubert-Combiescu, M. Seghier, V. Caro, R. Crainic, and F. Delpeyroux. 2001. Genomic features of intertypic recombinant Sabin poliovirus excreted by primary vaccinees. J. Virol. 75:5740-5751.
5. Dedepsidis, E., I. Karakasiliotis, E. Paximadi, Z. Kyriakopoulou, D. Komiotis, and P. Markoulatos. 2006. Detection of unusual mutation within the VP1 region of different re-isolates of poliovirus Sabin vaccine. Virus Genes 33:183-191.
6. Dedepsidis, E., V. Pliaka, Z. Kyriakopoulou, C. Brakoulias, S. LevidiotouStefanou, A. Pratti, Z. Mamuris, and P. Markoulatos. 2008. Complete genomic characterization of an intertypic Sabin 3/Sabin 2 capsid recombinant. FEMS Immunol. Med. Microbiol. 52:343-351.
7. Dömök, I., E. Molnár, and A. Jancso. 1961. Virus excretion after mass vaccination with attenuated polioviruses in Hungary. Br. Med. J. 5237:1410-1417.
8. Filman, D. J., R. Syed, M. Chow, A. J. Macadam, P. D. Minor, and J. M. Hogle. 1989. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 8:1567-1579.
9. Georgopoulou, A., and P. Markoulatos. 2001. Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes. Eur. J. Clin. Microbiol. Infect. Dis. 20:792-799.
10. Greening, G. E., J. Hewitt, and G. D. Lewis. 2002. Evaluation of integrated cell culture-PCR (C-PCR) for virological analysis of environmental samples. J. Appl. Microbiol. 93:745-750.
11. Guillot, S., V. Caro, N. Cuervo, E. Korotkova, M. Combiescu, A. Persu, A. Aubert-Combiescu, F. Delpeyroux, and R. Crainic. 2000. Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J. Virol. 74:8434-8443.
12. Hogle, J. M., M. Chow, and D. J. Filman. 1985. Three-dimensional structure of poliovirus at 2.9 Å resolution. Science 229:1358-1365.
13. Hovi, T., S. Blomqvist, E. Nasr, C. C. Burns, T. Saijakoski, N. Ahmed, C. Savolainen, M. Roivainen, M. Stenvik, P. Laine, I. Barakat, M. H. Wahdan, F. A. Kamel, H. Asghar, M. A. Pallansch, O. M. Kew, H. E. Gary, Jr., E. M. deGourville, and L. El Bassioni. 2005. Environmental surveillance of wild poliovirus circulation in Egypt-balancing between detection sensitivity and workload. J. Virol. Methods 126:127-134.
14. Hovi, T. 2006. Surveillance for polioviruses. Biologicals 34:123-126.
15. Huang, Q. S., G. Greening, M. G. Baker, K. Grimwood, J. Hewitt, D. Hulston, L. van Duin, A. Fitzsimons, N. Garrett, D. Graham, D. Lennon, H. Shimizu, T. Miyamura, and M. A. Pallansch. 2005. Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand. Lancet 366:394-396.
16. Karakasiliotis, I., P. Markoulatos, and T. Katsorchis. 2004. Site analysis of recombinant and mutant poliovirus isolates of Sabin origin from patients and from vaccinees. Mol. Cell. Probes 18:103-109.
17. Karakasiliotis, I., E. Paximadi, and P. Markoulatos. 2005. Evolution of a rare vaccine-derived multirecombinant poliovirus. J. Gen. Virol. 86:3137-3142.
18. Kew, O. M., P. F. Wright, V. I. Agol, F. Delpeyroux, H. Shimizu, N. Nathanson, and M. A. Pallansch. 2004. Circulating vaccine-derived poliovirus: current state of knowledge. Bull. W. H. O. 82:16-23.
19. Kohara, M., T. Omata, A. Kameda, B. L. Semler, H. Itoh, E. Wimmer, and A. Nomoto. 1985. In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain. J. Virol. 53:786-792.
20. Lewis, G. D., and T. G. Metcalf. 1988. Polyethylene glycol precipitation for recovery of pathogenic viruses, including hepatitis A virus and human rotavirus, from oyster, water, and sediment samples. Appl. Environ. Microbiol. 54:1983-1988.
21. Lipskaya, G. Y., A. R. Muzychenko, O. K. Kutitova, S. V. Maslova, M. Equestre, S. G. Drozdov, R. P. Bercoff, and V. I. Agol. 1991. Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine-associated polio cases. J. Med. Virol. 35:290-296.
22. Macadam, A. J., S. R. Pollard, G. Ferguson, R. Skuce, D. Wood, J. W. Almond, and P. D. Minor. 1993. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. Virology 192:18-26.
23. Martin, J., E. Samoilovich, G. Dunn, A. Lackenby, E. Feldman, A. Heath, E. Svirchevskaya, G. Cooper, M. Yermalovich, and P. D. Minor. 2002. Isolation of an intertypic poliovirus capsid recombinant from a child with vaccineassociated paralytic poliomyelitis. J. Virol. 76:10921-10928.
24. Ministerio de Salud de la Provincia de Córdoba, Secretaría de Salud de la Municipalidad de Córdoba, Comitato Internazionale per lo Sviluppo del Popoli. 1991. Vigilancia Epidemiológica de las Enfermedades Transmisibles - Córdoba 1970-1989. Ediciones Cincos. Ministerio de Salud de la Provincia de Córdoba, Córdoba, Argentina.
25. Minor, P. D., A. J. Macadam, D. M. Stone, and J. W. Almond. 1993. Genetic basis of attenuation of the Sabin oral poliovirus vaccines. Biologicals 21:357-363.
26. Paximadi, E., I. Karakasiliotis, Z. Mamuris, C. Stathopoulos, V. Krikelis, and P. Markoulatos. 2006. Genomic analysis of recombinant Sabin clinical isolates. Virus Genes 32:203-210.
27. Rakoto-Andrianarivelo, M., S. Guillot, J. Iber, J. Balanant, B. BlondeL F. Riquet, J. Martin, O. Kew, B. Randriamanalina, L Razafinimpiasa, D. Rousset, and F. Delpeyroux. 2007. Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar. PLoS Pathog. 3:e191.
28. Rezapkin, G. V., M. Douthitt, E. Dragunsky, and K. M. Chumakov. 1999. Reevaluation of nucleotide sequences of wild-type and attenuated polioviruses of type 3. Virus Res. 65:111-119.
29. Romanenkova, N. I., S. Guillot, N. R. Rozaeva, R. Crainic, M. A. Bichurina, and F. Delpeyroux. 2006. Use of a multiple restriction fragment length polymorphism method for detecting vaccine-derived polioviruses in clinical samples. J. Clin. Microbiol. 44:4077-4084.
30. Shulman, L. M., Y. Manor, D. Sofer, R. Handsher, T. Swartz, F. Delpeyroux, and E. Mendelson. 2006. Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations. PLoS ONE 1:e69.
31. Tardy-Panit, M., B. Blondel, A. Martin, F. Tekaia, F. Horaud, and F. Delpeyroux. 1993. mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice. J. Virol. 67:4630-4638.
32. Tatem, J. M., C. Weeks-Levy, A. Georgiu, S. J. DiMichele, E. J. Gorgacz, V. R. Racaniello, F. R. Cano, and S. J. Mento. 1992. A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating. J. Virol. 66:3194-3197.
33. Weeks-Levy, C., J. M. Tatem, S. J. DiMichele, W. Waterfield, A. F. Georgiu, and S. J. Mento. 1991. Identification and characterization of a new base substitution in the vaccine strain of Sabin 3 poliovirus. Virol. 185:934-937.
34. World Health Organization. 2003. Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine-using countries: W. H. O. position paper. Wkly. Epidemiol. Rec. 78:241-250.
35. World Health Organization. 2003. Guidelines for environmental surveillance of poliovirus circulation. WHO, Geneva, Switzerland, http://www.who.int/vaccines-documents/DocsPDF03/www737.pdf.
36. World Health Organization. 2004. Polio laboratory manual, 4th ed. WHO, Geneva, Switzerland. httpy/www.who.int/vaccines/en/poliolab/WHO-Polio- Manual-9.pdf.
37. World Health Organization. 2006. Inactivated polio vaccine following oral polio vaccine cessation. Wkly. Epidemiol. Rec. 81:137-144.
38. World Health Organization. 2007. Global update on vaccine-derived polioviruses, January 2006-August 2007. Wkly. Epidemiol. Rec. 82:337-344.
39. Yang, C. F., T. Naguib, S. J. Yang, E. Nasr, J. Jorba, N. Ahmed, R. Campagnoli, H. van der Avoort, H. Shimizu, T. Yoneyama, T. Miyamura, M. Pallansch, and O. Kew. 2003. Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J. Virol. 77:8366-8377.
40. Matsuura, K., M. Ishikura, H. Yoshida, T. Nakayama, S. Hasegawa, S. Ando, H. Horie, T. Miyamura, and T. Kitamura. 2000. Assessment of poliovirus eradication in Japan: genomic analysis of poliovirus isolated from river water and sewage in Toyama prefecture. Appl. Environ. Microbiol. 66:5087-5091.